These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 7525363

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
    Liu H, Zhu P, Lin NJ, Zhang Y, Bu DF, Wang YJ, Wang YQ, Yang Y.
    Zhonghua Yi Xue Za Zhi; 2004 Jan 02; 84(1):48-53. PubMed ID: 14990159
    [Abstract] [Full Text] [Related]

  • 24. An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.
    Pericle F, Giovarelli M, Colombo MP, Ferrari G, Musiani P, Modesti A, Cavallo F, Di Pierro F, Novelli F, Forni G.
    J Immunol; 1994 Dec 15; 153(12):5659-73. PubMed ID: 7989764
    [Abstract] [Full Text] [Related]

  • 25. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.
    Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137
    [Abstract] [Full Text] [Related]

  • 26. Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.
    Mortara L, Frangione V, Castellani P, De Lerma Barbaro A, Accolla RS.
    Int Immunol; 2009 Jun 15; 21(6):655-65. PubMed ID: 19395374
    [Abstract] [Full Text] [Related]

  • 27. Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines.
    Stoppacciaro A, Paglia P, Lombardi L, Parmiani G, Baroni C, Colombo MP.
    Eur J Immunol; 1997 Sep 15; 27(9):2375-82. PubMed ID: 9341783
    [Abstract] [Full Text] [Related]

  • 28. Differential cytokine gene expression in CD4+ and CD8+ T cell subsets of calves.
    Tanaka S, Aso H, Miyazawa K, Nagai Y, Watanabe K, Ohwada S, Kobayashi J, Yamaguchi T.
    Vet Immunol Immunopathol; 2007 Jul 15; 118(1-2):84-91. PubMed ID: 17543393
    [Abstract] [Full Text] [Related]

  • 29. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.
    Tannenbaum CS, Wicker N, Armstrong D, Tubbs R, Finke J, Bukowski RM, Hamilton TA.
    J Immunol; 1996 Jan 15; 156(2):693-9. PubMed ID: 8543822
    [Abstract] [Full Text] [Related]

  • 30. Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes.
    Evans R, Kamdar SJ, Duffy T, Edison L.
    J Immunol; 1993 Jan 01; 150(1):177-84. PubMed ID: 8417123
    [Abstract] [Full Text] [Related]

  • 31. Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma.
    De Giovanni C, Nicoletti G, Landuzzi L, Rossi I, Astolfi A, Ricci C, Di Carlo E, Musiani P, Forni G, Fradelizi D, Nanni P, Lollini PL.
    Gene Ther; 2001 Nov 01; 8(22):1698-704. PubMed ID: 11892837
    [Abstract] [Full Text] [Related]

  • 32. Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer.
    Reome JB, Hylind JC, Dutton RW, Dobrzanski MJ.
    Clin Immunol; 2004 Apr 01; 111(1):69-81. PubMed ID: 15093554
    [Abstract] [Full Text] [Related]

  • 33. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K, Saio M, Suwa T, Frey AB, Umemura N, Imai H, Ouyang GF, Osada S, Balazs M, Adany R, Kawaguchi Y, Yoshida K, Takami T.
    J Leukoc Biol; 2008 Sep 01; 84(3):679-88. PubMed ID: 18566103
    [Abstract] [Full Text] [Related]

  • 34. Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.
    Adris S, Chuluyan E, Bravo A, Berenstein M, Klein S, Jasnis M, Carbone C, Chernajovsky Y, Podhajcer OL.
    Cancer Res; 2000 Dec 01; 60(23):6696-703. PubMed ID: 11118055
    [Abstract] [Full Text] [Related]

  • 35. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L, Castellani P, Meazza R, Tosi G, De Lerma Barbaro A, Procopio FA, Comes A, Zardi L, Ferrini S, Accolla RS.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [Abstract] [Full Text] [Related]

  • 36. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
    Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G.
    Cell Immunol; 1994 Jul 01; 156(2):480-92. PubMed ID: 7912999
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Expression of non-T cell derived cytokines in acute rejection after heart transplantation: experiment with mouse model].
    Liang TB, Yu ZY, Zheng SS.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 03; 86(1):26-30. PubMed ID: 16606531
    [Abstract] [Full Text] [Related]

  • 39. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun 03; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 40. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.
    Giovarelli M, Musiani P, Modesti A, Dellabona P, Casorati G, Allione A, Consalvo M, Cavallo F, di Pierro F, De Giovanni C.
    J Immunol; 1995 Sep 15; 155(6):3112-23. PubMed ID: 7673726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.